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In contrast to C57BL/6 mice, BALB/c mice are relatively resistant to the induction of 
experimental autoimmune encephalomyelitis (EAE) after challenge with MOG35–55 peptide. 
Here, we provide the first evidence that infection with murine cytomegalovirus (MCMV) 
in adulthood abrogates this resistance. Infected BALB/c mice developed clinical and 
histological signs similar to those seen in susceptible C57BL/6 mice. In addition to CD4+ 
cells, large proportion of cells in the infiltrate of diseased BALB/c mice was CD8+, similar 
with findings in multiple sclerosis. CD8+ cells that responded to ex vivo restimulation with 
MOG35–55 were not specific for viral epitopes pp89 and m164. MCMV infection favors 
proinflammatory type of dendritic cells (CD86+CD40+CD11c+) in the peripheral lymph 
organs, M1 type of microglia in central nervous system, and increases development of 
Th1/Th17 encephalitogenic cells. This study indicates that MCMV may enhance auto-
immune neuropathology and abrogate inherent resistance to EAE in mouse strain by 
enhancing proinflammatory phenotype of antigen-presenting cells, Th1/Th17, and CD8 
response to MOG35–55.
Keywords: experimental autoimmune encephalomyelitis, BalB/c mice, murine cytomegalovirus infection, 
antigen-presenting cells, T cells
inTrODUcTiOn
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating disease of the central nervous 
system (CNS) with axonal injury, characterized by varying clinical course, pathology, and inflamma-
tory patterns (1). It develops in susceptible hosts after interaction with environmental factors which 
trigger the disease by promoting the activation of myelin-specific T cells that normally circulate 
in the peripheral lymph organs of all individuals (2). It has been suggested that some infectious 
agents, in particular viruses, may be potential triggers of MS (2–4). Among different infective agents, 
Epstein–Barr virus (EBV) has been mostly associated with increased MS risk (5). Recently, it has 
been shown increased CD8+ T cell response to EBV lytic antigens in active MS and also in relapses 
(6). Infection with murine gamma herpesvirus 68 (γHV-68), the murine homolog to EBV, polarizes 
the adaptive immune response and heightens CNS pathology following experimental autoimmune 
encephalomyelitis (EAE) induction and likely, influences MS pathogenesis (7).
2Milovanovic et al. MCMV Infection Overcomes Resistance to EAE
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 192
Experimental autoimmune encephalomyelitis is the experi-
mental model of MS, induced in susceptible animals by active 
immunization with myelin antigens mixed with adjuvant (8). 
Immunized mice develop ascending paralysis with CD4+ T 
cells and macrophages in infiltrations in the white matter of 
the spinal cord, and with minimal brain inflammation in the 
majority of experimental models. However, in MS, the vast 
majority of myelin lesions are found within the brain paren-
chyma with infiltrations that contain equivalent numbers of 
CD8+ T and CD4+ T cells (9, 10). Despite these differences, EAE 
is considered as a valuable tool for research of MS pathogen-
esis. Moreover, several therapeutics that are now being used to 
treat MS were developed in EAE (11). BALB/c mice are found 
partially or completely resistant to the induction of EAE with 
encephalitogenic peptide, myelin oligodendrocyte glycoprotein 
(MOG35–55).
Cytomegalovirus (CMV) classified within the Betaherpesvirinae 
subfamily establishes life-long latent infections in 70–100% 
of the human population (12). After a primary infection of 
fibroblasts, epithelial, endothelial, and smooth muscle cells (6), 
mostly asymptomatic in the immunocompetent host, CMV 
persists in myeloid precursor cells (7). During latency periodic 
asymptomatic reactivations occur (13). CMV contains a large 
number of latent and lytic genes, many of which code proteins 
that have the role in immunoregulation (5). When monocytes 
that carry CMV enter visceral parenchyma and differentiate into 
macrophages and myeloid dendritic cells, virus reactivates and 
through expression of different genes can modulate the immune 
response of the host (14).
Data on the role of CMV infection in etiopathogenesis of MS 
are controversial. CMV has been found in demyelinating plaques 
and the cerebrospinal fluid of MS patients (15) and causes demy-
elination mainly in the CNS of immunocompromised hosts (16). 
Further, enhancement of numbers of EBV and CMV-specific 
CD8+ T cells among T cells in chronic inflammatory lesions of 
brain of MS patients was reported (17). Several studies involving 
human subjects indicate correlation between CMV infection 
and MS development, greater rate of relapses and greater brain 
atrophy (18–20). Other studies indicate that CMV seropositiv-
ity is associated with a decreased MS risk and predicts a better 
clinical and radiological outcome in MS patient (21), suggesting 
a protective effect of CMV on autoimmune neuropathology (22). 
Furthermore, CMV encodes multiple factors that trigger immu-
nomodulatory or evasion mechanisms, which can decrease the 
immune response in MS patients (23, 24).
We have recently shown that deletion of an immunoregulatory 
pathway, IL-33/ST2 axis, may enhance susceptibility to EAE in 
resistant BALB/c strain (25, 26). The present study was done with 
the aim to explore whether infection with murine CMV (MCMV) 
create “fertile field” (27, 28) that facilitates the expansion and acti-
vation of encephalitogenic cells leading to autoimmune disease 
of CNS.
Here, we show that MCMV infected and MOG35–55 immunized 
BALB/c mice develop very pronounced neuroinflammation with 
extensive infiltrations in brain and spinal cord parenchyma con-
taining large proportion of CD8+ cells in infiltrates in addition 
to accentuation of Th1 and Th17 immune response and skewing 
microglia to M1 phenotype. Our results are compatible with the 
notion that MCMV abrogates inherent resistance of BALB/c mice 
to EAE induction with MOG35–55 peptide through enhancement 
of inflammatory dendritic cells in the periphery, M1 type of 
microglia and recruitment of MOG35–55 responsive CD8+ T cells 
in the CNS. Thus, CMV-induced inflammatory environment may 
enhance autoimmunity in CNS.
MaTerials anD MeThODs
infection, induction, and scoring of eae
Female 8-week-old BALB/c mice were used throughout this 
study. Mice were infected subcutaneously (footped) with 105 
plaque-forming units of tissue culture MCMV, strain MW97.01 
(29). EAE was induced 10 days after infection by subcutaneous 
administration of 200 µL suspension at two sites over the hind 
flanks. Depletion of CD4+ lymphocytes, where indicated, was 
performed with intraperitoneal injection of 100 µg of anti-CD4 
mAb, 1 day prior to and 5 days after MOG35–55 immunization. 
The suspension consisted of 300 µg MOG35–55 peptide (Sigma-
Aldrich, Germany) in 100  µL of PBS, emulsified with 100  µL 
complete Freund’s adjuvant (Sigma-Aldrich, Germany) with 
0.7  mg heat-inactivated Mycobacterium tuberculosis (strain 
H37 RA; Difco Laboratories, Detroit, MI, USA). Each mouse 
was immediately thereafter, injected intraperitoneally and 48 h 
later with 300 ng pertussis toxin (List Biological Laboratories, 
Campbell, CA, USA) in 100  µL 0.9% NaCl. Clinical signs of 
EAE were assessed daily by the following scoring system: grade 
0, no signs; grade 1, paralyzed tail; grade 2, ataxic; grade 2.5, 
one hind leg paralyzed; grade 3, both hind legs paralyzed; grade 
3.5, three legs paralyzed; grade 4, both hind legs and front limbs 
completely paralyzed; grade 5, moribund as previously described 
(30, 31). Mice were monitored daily with fluid administration 
and mashed chow on the base of cages for all mice displaying a 
clinical score of 3. Mice were maintained in our animal facilities 
in a temperature-controlled environment with a 12-h light/12-h 
dark cycle and were administered standard laboratory food 
and water ad  libitum. All experiments were approved by and 
conducted in accordance with the Guidelines of the Animal 
Ethics Committee of Faculty of Medical Sciences, University of 
Kragujevac, Serbia. Endangered animal species were not used 
in this study.
isolation of Mononuclear cells from cns 
and lymph nodes
At day 15 post-EAE induction (mean clinical score of 3 for MCMV 
EAE mice), mice were perfused with PBS, and brain and spinal 
cord were carefully removed. The mononuclear cells from CNS 
were isolated as described previously (25). Briefly, the brains and 
spinal cords were homogenized in RPMI 1640 (Sigma-Aldrich) 
with 10% FBS and 1 mg/mL collagenase type I (Sigma-Aldrich) 
and incubated at 37°C for 60 min. After digestion, the tissue was 
passed through a 40-µm mesh, pelleted, resuspended in 10 mL 
30% Percoll (Sigma-Aldrich), overlaid onto 5 mL 70% Percoll, and 
centrifuged at 390 g for 20 min. The myelin layer was removed, 
and the mononuclear cells accumulated in the intermediate 
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phase were collected, washed twice in PBS, and resuspended 
in RPMI 1640 containing 10% FBS. Total cell numbers were 
determined by counting on a hemocytometer, and viability was 
assessed by trypan blue exclusion. Lymph nodes were minced in 
RPMI 1640 (Sigma-Aldrich) and forced gently through 40-µm 
cell-strainer nylon mesh (Falcon) using a sterile syringe plunger 
and centrifuged at 400 g for 5 min. Pellet from lymph nodes was 
resuspended in RPMI 1640 containing 10% FBS.
Flow cytometry
Single-cell suspensions of brain and spinal cord tissue were pre-
pared according to standard protocols. For cytofluorometry, fol-
lowing antibodies were used: CD4, CD8, CD45, CCR6, CXCR3, 
TCRβ, CD11c, CD11b, CD49b, CCR2, CD86, T-bet, RORγt, 
IL-17, IFN-γ, TNF-α, and IL-12 with conjugated fluorochromes 
(BD Biosciences). Antibodies were incubated with cells in PBS 
with 2% FBS for 30  min at 4°C, and then cells were analyzed. 
For intracellular staining of cytokines, cells were stimulated for 
4 h in RPMI 1640 containing 10% FBS (Gibco), 10 ng/mL phor-
bol 12-myristate 13-acetate (Sigma-Aldrich), and 500  ng/mL 
ionomycin (Sigma-Aldrich) with addition of Brefeldin A (BD 
Biosciences). Antibodies for the cell surface markers were added 
to the cells in PBS with 2% FBS for 30 min on ice. After wash, cells 
were resuspended in Cytofix/Cytoperm buffer (BD Biosciences) 
for 20  min on ice, washed twice, and incubated with Abs for 
intracellular antigens (cytokines) in Perm buffer (30 min, on ice). 
For staining of transcriptional factors, unstimulated cells were 
used. Data were acquired using FACSCalibur (BD Biosciences) 
and analyzed with FlowJo software (Tree Star).
Tetramer staining
Immune cells were isolated as described above. Cells isolated 
from CNS were incubated with H-2L(d)/IE-1/pp89 (168–176 
YPHFMPTNL) and H-2D(d)/m164 (257–265 AGPPRYSRI) 
tetramers provided by NIH tetramer core facility. Cells stained 
with tetramer and anti-CD8 and anti-CD3 antibodies were 
incubated for 30  min at room temperature and then washed. 
Data were acquired using a FACSCalibur (BD Biosciences) and 
analyzed with FlowJo software (Tree Star).
immunohistochemistry and evaluation of 
Brain and spinal cord Pathology
Brains and spinal cords were fixed in 4% buffered formalin 
fixative overnight. Paraffin wax embedded sections (5 µm) were 
stained with hematoxylin and eosin and CD3 (ab699; Abcam) 
immunohistochemical staining. The slides were analyzed on light 
microscope (BX51; Olympus), and digital images were acquired 
by digital camera. The level of infiltration was graded using 
the following score: 0, no inflammatory cells; 1, a few scattered 
inflammatory cells; 2, organization of inflammatory infiltrates 
into perivascular cuffs; 3, extensive perivascular cuffing with 
extension into adjacent subarachnoid space and CNS paren-
chyma, and 4, extensive perivascular cuffing with increasing 
subarachnoid and parenchymal inflammation (32). Slides were 
analyzed on Olympus BX51 microscope, and digital images were 
acquired by Olympus digital camera (DP71).
interferon-γ assay
Mononuclear cells isolated from CNS, 105 in 100  µL complete 
media were put on 96-well plate in duplicates, and 100  µL of 
media, or MOG35–55 (1 μg/well) were added. After incubation for 
1 h on 37°C, 0.2 µL of Brefeldin A in 10 µL of medium was added 
to each well and incubated for 4 h on 37°C. Cells were washed and 
then incubated with anti-CD8 and anti-CD4 antibodies on +4°C 
for 15  min. After washing, cells were resuspended in Cytofix/
Cytoperm buffer for 30 min on ice, washed twice, and incubated 
with anti-IFNγ antibodies diluted in Perm wash buffer (30 min, 
on ice) and resuspended in FACS media.
statistical analysis
All statistics were carried out using SPSS 18.0 for Windows 
software. Results were analyzed using the Student’s t-test or 
Mann–Whitney test and ANOVA or Kruskal–Wallis. Data in this 
study were expressed as the mean + SEM. Values of P < 0.05 were 
considered significant.
resUlTs
McMV infection in adult life abrogates 
resistance to eae in BalB/c Mice
BALB/c mice immunized with MOG35–55 did not develop clinical 
signs of EAE, while BALB/c mice infected with MCMV 8 weeks 
after birth and 10 days later challenged with MOG35–55 in CFA 
and pertussis toxin (MCMV  +  MOG35–55) developed clinical 
signs that correspond to EAE manifestations seen in C57BL/6 
mice (Figure  1A). Based on evaluation of clinical course 
(Figure  1A) and mean maximal clinical score (Figure  1B), 
MCMV-infected BALB/c mice developed disease indistinguish-
able from disease in susceptible C57BL/6 mice. Infiltration in 
CNS of MCMV +  MOG35–55, expressed by mean histological 
score (Figure 1D) and total cell number (Figure 1C), was sig-
nificantly higher compared with BALB/c mice immunized with 
MOG35–55 only mice. BALB/c mice infected with MCMV and 
10 days later immunized with MOG35–55 developed subarachnoid 
and perivascular infiltrations in the brain cortex, perivascular 
infiltrations in brainstem and cerebellum with spreading to 
parenchyma (Figure 1E), and white matter spinal cord infiltra-
tions (Figure 1F). Single-cell infiltrates were detected in brains 
and spinal cords of MOG35–55-immunized mice only, and 
mild perivascular infiltrations were detected in brainstem of 
MCMV-infected mice (Figures 1E,F). Immunostaining of spinal 
cord sections showed presence of CD3+ cells in the infiltrates 
(Figure 1G).
cns infiltrates of McMV + MOg35–55 Mice 
contain higher amounts of T1/T17 cD4+ 
and cD8+ T cells
Further analysis showed significantly higher number of CD4+ 
and CD8+ T cells in the infiltrates of MCMV + MOG35–55 mice 
compared with MOG35–55 mice (Figure  2A). In the CNS of 
MCMV + MOG35–55 mice, there was higher number of CD4+ T 
cells then CD8+ T cells, similar to typical EAE in C57BL/6 mice. 
FigUre 1 | continued
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FigUre 1 | continued 
BalB/c mice infected with murine cytomegalovirus (McMV) and immunized with MOg35–55 develop experimental autoimmune encephalomyelitis 
(eae). Eight-week-old BALB/c mice were infected (foot-pad injection) with MCMV and 10 days after were immunized with MOG35–55 peptide in CFA and pertussis 
toxin (BALB/c MCMV + MOG35–55). Control mice C57BL/6 and BALB/c were immunized with MOG35–55 peptide in CFA and pertussis toxin without previous infection 
(C57BL/6 MOG35–55 and BALB/c MOG35–55). (a) EAE scores up to day 15 post-EAE induction (four separate experiments, n = 29/group). (B) Mean maximal clinical 
score up to day 15 post-EAE induction (four separate experiments, n = 29/group). (c) The mean value of the mononuclear cells isolated from central nervous 
system (CNS) of BALB/c MCMV + MOG35–55 and BALB/c MOG35–55 mice (three independent experiments, n = 24/group). (D) Mean histological scores were 
calculated from a total of five sections per group (two separate experiments, n = 8/group). (e) The representative images of brain cortex (a), brain stem (b), 
cerebellum (c) of BALB/c MCMV + MOG35–55; brain cortex (d), brain stem (e), cerebellum (f) of BALB/c MCMV-infected mice (BALB/c MCMV); and brain cortex (g), 
brain stem (h), cerebellum (i) of BALB/c MOG35–55 mice. (F) The representative images of spinal cords of BALB/c MCMV + MOG35–55 (a–c); BALB/c MCMV (d); and 
BALB/c MOG35–55 mice (e). (g) Representative sections of CD3 spinal cord immunohistochemistry of BALB/c MCMV + MOG35–55 (a,b); BALB/c MCMV (c); and 
BALB/c MOG35–55 mice (d), arrows in left panels indicate the area presented in magnified sections in right panels. All pictures are representative of two separate 
experiments (n = 16/group). Data were analyzed by Student’s t-test and presented as mean + SE: *P < 0.05 and ***P < 0.001.
5
Milovanovic et al. MCMV Infection Overcomes Resistance to EAE
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 192
MCMV + MOG35–55 mice had increased percentage (Figure 2B) 
and number (Figure 2C) of both Th1 and Th17 cells, as well as Tc1 
and Tc17 cells compared to MOG35–55 mice. Similarly, significantly 
higher number of CD4+ cell- and CD8+ cell-expressing transcrip-
tional factors, T-bet and RORγt (Figure  2D), and chemokine 
receptors CCR6 and CXCR3 (Figure 2E) was noticed in CNS of 
MCMV + MOG35–55 mice compared with MOG35–55 mice.
cD8+ cells Take a role in autoimmune 
neuropathology in BalB/c Mice with 
McMV infection
Depletion of CD4+ cells in MCMV-infected mice abrogated sus-
ceptibility to MOG35–55-induced disease (Figure 3A) indicating 
autoimmune disease. Given the significant number of CD8+ cells 
in the infiltrates that were not seen in classical EAE, we explored 
in more details these cells found in CNS. There was significantly 
higher percentage and number of CD8+ cell-expressing markers of 
cytolytic activity in the CNS of MCMV + MOG35–55 BALB/c mice 
compared to MOG35–55 mice (Figure 3B). To indirectly determine 
the percentage of MOG35–55-specific CD4+ and CD8+ cells, mono-
nuclear cells were isolated from CNS of MCMV +  MOG35–55 
BALB/c, MOG35–55 BALB/c, and MOG35–55 C57BL/6 mice and ex 
vivo restimulated with MOG35–55 peptide, and IFN-γ+ cells were 
enumerated. Significantly higher percentage of CD4+ and CD8+ 
cells from CNS of MCMV +  MOG35–55 mice responded to ex 
vivo restimulation compared with MOG35–55 only BALB/c mice 
(Figure  3C). Further, significantly higher percentage of CD8+ 
cells isolated from CNS of MCMV +  MOG35–55 BALB/c mice 
contained IFN-γ after ex vivo restimulation with MOG35–55 com-
pared to C57BL/6 mice immunized with MOG35–55. Even more 
importantly, IFN-γ-containing CD8+ cells in MCMV + MOG35–55 
BALB/c mice after restimulation with MOG35–55 were not specific 
for viral epitopes pp89 and m164, suggesting that inflammatory 
CD8+ cells in the CNS are autoimmune (Figure 3D).
chronic non-Productive McMV infection 
also Facilitates eae Development in 
BalB/c Mice
In order to test whether the chronic non-productive MCMV 
infection could facilitate EAE development, we immunized 
BALB/c mice with MOG35–55 peptide 3 months after MCMV infec-
tion in adult life. As shown in Figure 4, infected mice developed 
clinical signs of EAE while age-matched mice immunized with 
encephalitogen only, did not. Mice with chronic non-productive 
MCMV infection started to manifest signs of EAE 6 days after 
immunization with MOG35–55 peptide; maximal clinical score 
reached 15 days after immunization and had very mild signs of 
the disease 60  days after immunization (Figure  4A). Chronic 
disease was confirmed with histological analysis. Perivascular 
infiltrates were detected in the spinal cords of mice with latent 
MCMV infection 2 months after challenge with MOG35–55 peptide 
(Figure 4B). Among cells isolated from brains of MCMV-infected 
BALB/c mice 2  months after MOG35–55 immunization, higher 
percentage of CD4+ and CD8+ cells contained inflammatory 
cytokines IL-17 and IFN-γ, after in  vitro restimulation with 
MOG35–55 peptide compared to stimulated cells isolated from 
MOG35–55-immunized mice (Figure  4C). Our findings indicate 
that BALB/c mice with latent MCMV infection develop disease 
with long-lasting infiltrates in the CNS that contains lymphocytes 
specific for neuroantigens.
McMV infection induces inflammatory 
Phenotype of antigen-Presenting cells in 
Periphery and in cns
It is known that viral infection induces antiviral immune response 
mediated by NK cells, CD8+ and CD4+ lymphocytes (33). Such 
inflammatory microenvironment in peripheral lymph organs 
can affect activation of antigen-presenting cells and thus indi-
rectly contribute to development of inflammatory lymphocytes. 
Therefore, we explored possible influence of viral infection on 
changes of phenotype of antigen-presenting cells. To this end, 
mononuclear cells were isolated from inguinal lymph node 
12 days after MCMV was administered in foot pad and com-
pared with cells isolated from mice immunized with MOG35–55 
only. Lymph nodes of MCMV-infected and MCMV + MOG35–55 
mice had significantly higher percentage of CD11c+ dendritic 
cells and CD11c+PDCA1+plasmocitoid dendritic cells in 
inguinal lymph nodes compared to MOG35–55-immunized mice 
(Figure 5A). Also higher percentage of dendritic cell-expressing 
CCR2 chemokine receptor was found in both groups of MCMV-
infected mice (Figure 5B). More importantly, lymph nodes of 
MCMV-infected and MCMV  +  MOG35–55 mice contained 
higher percentage of activated CD86+ and CD40+ (Figure 5C) 
and inflammatory IL-12+ dendritic cells (Figure  5E). Higher 
FigUre 2 | BalB/c murine cytomegalovirus (McMV) + MOg35–55 mice have increased number of inflammatory cD4+ and cD8+ cells. Eight-week-old 
BALB/c mice were infected with MCMV and 2 weeks after were immunized with MOG35–55 peptide. After 15 days, mice were perfused, central nervous system was 
harvested, and mononuclear cells were isolated and restimulated ex vivo with PMA and ionomycin before performing intra cellular staining. (a) Total cell numbers of 
CD45+CD4+, CD45+CD8+ cells. (B) Representative FACS images of percentages and (c) total cell numbers of CD4+IFN-γ+, CD4+TNF-α+, CD4+IL-17+, CD8+IFN-γ+, 
CD8+TNF-α+ and CD8+IL-17+ cells. Total cell numbers of CD8+ cell- and CD4+ cell-expressing transcriptional factors T-bet and RORγt (D) and chemokine receptors 
CXCR3 and CCR6 (e). Data from three separate experiments with 22 mice/group are presented as mean + SE. Data were analyzed with Student’s t-test: *P < 0.05, 
**P < 0.005, and ***P < 0.001.
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FigUre 3 | cD8 T cells in the central nervous system (cns) of BalB/c murine cytomegalovirus (McMV) + MOg35–55 mice express markers of 
cytolytic activity and contribute to autoimmune reactions in cns. CD4+ cells were depleted 10 days after MCMV infection and 5 days before immunization 
with MOG35–55 (anti-CD4), control mice were infected and immunized but received saline instead of depleting antibody (saline). (a) Experimental autoimmune 
encephalomyelitis (EAE) scores up to day 22 post-EAE induction in anti-CD4 and saline mice, data are presented as mean + SE from one experiment with five mice 
per group. (B) Percentages and absolute numbers of CD8+granzyme B+ and CD8+perforin+ cells among mononuclear cells isolated from CNS 15 days post-
immunization with MOG35–55 peptide of BALB/c mice infected with MCMV 10 days earlier (MCMV + MOG35–55) and previously untreated BALB/c mice (MOG35–55). 
Data are presented as mean + SE, from two separate experiments with 14 mice/group. (c) Percentages of CD4+IFN-γ+ and CD8+IFN-γ+ cells and (D) representative 
flow images of IFN-γ, pp89, and m164 expression in CD8+ population among mononuclear cells isolated from CNS of MCMV-infected and MOG35–55-immunized 
BALB/c mice and MOG35–55-immunized BALB/c and C57BL/6 mice in vitro restimulated with MOG35–55 peptide. Percentages are presented as mean + SE 
(representative experiment with six mice per group). Data were analyzed with Student’s t-test and Kruskal–Wallis: *P < 0.05, **P < 0.005.
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expression of markers of activation, CD86+ and CD40+ was 
noticed in MCMV-infected mice compared with MOG35–55-
immunized mice (Figure 5D). These data suggest that inflam-
matory phenotype of dendritic cells is achieved in BALB/c mice 
with viral infection but not with encephalitogenic challenge 
only, as it was seen in C57BL/6 mice.
It is known that systemic inflammation in mice causes 
activation of microglia that persists for months (34, 35). Since 
MCMV infection in BALB/c mice causes systemic inflamma-
tion, we wanted to see effect of MCMV infection on phenotype 
of antigen-presenting cells in CNS. We analyzed expression 
of markers of classical (CD11c) and alternative activation 
FigUre 4 | BalB/c mice with latent murine cytomegalovirus (McMV) infection develop experimental autoimmune encephalomyelitis and longlasting 
infiltrates in central nervous system. Mice were infected with MCMV, and 3 months later they were immunized with MOG35–55 peptide, and disease was 
evaluated for 60 days. (a) Mean clinical score and (B) representative images of spinal cord sections 60 days after immunization with MOG35–55 peptide in 
MCMV + MOG35–55 group (a–c) and MOG35–55 group (d–f). (c) Representative flow cytometric images presenting percentages of IL-17- and IFN-γ-expressing CD4+ 
and CD8+ cells among mononuclear cells isolated from brains 60 days after immunization with MOG35–55 peptide. Presented data are from representative experiment 
with seven mice per group.
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(CD206) in the population of microglia (CD45intCD11b+) in 
healthy mice, MOG35–55-immunized mice, MCMV-infected, and 
MCMV + MOG35–55 mice. As shown in Figure 5F, microglia of 
mice with viral infection in adult life, with and without EAE, had 
proinflammatory, M1 phenotype. Significantly higher percentage 
of CD11c-expressing cells in microglia population was found in 
both groups of infected mice compared to healthy and MOG35–55-
immunized mice. On the other hand, the highest percentage of 
(type 2) CD206-expressing microglia was found in MOG35–55 
BALB/c mice. Higher percentage of M2 microglia was also found 
in MCMV +  MOG35–55-immunized mice compared to healthy 
and MCMV-infected mice but lower compared to MOG35–55-
immunized mice. Thus, high percentage of M2 microglia in mice 
at the peak of EAE could be also the compensatory mechanism 
that precedes disease attenuation.
DiscUssiOn
Here, we provide the first evidence that MCMV infection results 
in breaking resistance of BALB/c mice to EAE induction with 
MOG35–55 peptide, as indicated by typical clinical manifestations 
and massive inflammatory infiltration in the CNS (Figure 1).
The role of MCMV infection in EAE is not studied, while its 
significance in MS is controversial. There are several prospective 
clinical studies that indicate protective effect of CMV infection 
on MS risk (21, 22, 36), while recent well-powered meta-analysis 
found no significant difference in the rate of CMV seropositiv-
ity between MS patients and healthy controls based on pooled 
samples from all studies to date (37). On the other hand, CMV 
has been found in demyelinating plaques and the liquor of MS 
patients (15), and several clinical studies support the role of 
CMV in MS pathogenesis (18–20). Additionally, CMV infection 
induces expansion of inflammation-seeking/proinflammatory 
effector-memory CD4+CD28null T cells that are attracted to MS 
lesions via a CX3CL1 gradient (38, 39) and are mostly found in MS 
patients (40). Stimulation of these cells with myelin autoantigens 
results in their proliferation and release of cytotoxic granules, and 
thus may contribute to MS pathology (41). Some experimental 
animal studies support the role of CMV in EAE development. 
Cross-reactivity between CMV981–1,003 and MOG35–55 peptides was 
FigUre 5 | continued
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FigUre 5 | continued 
Murine cytomegalovirus (McMV) infection favors inflammatory phenotype of antigen-presenting cells. Mononuclear cells were isolated from inguinal 
lymph nodes 2 days after immunization with MOG35–55 peptide (MOG35–55) and from lymph nodes of mice 10 days after their MCMV infection (MCMV). Flow 
cytometric analysis of dendritic cells phenotype was done. (a) Percentages and absolute numbers of CD11c+ dendritic cells and CD11c+CD11b−PDCA1+ dendritic 
cells, (B) CCR2-expressing CD11c+ cells, and (c) CD86+ and CD40+ dendritic cells are presented as mean + SE (10 mice per group). (D) Representative 
histograms of CD40 and CD86 expression in CD11c+ population. (e) Percentages and absolute numbers of IL-12+ dendritic cells presented as mean + SE (10 mice 
per group). (F) Mononuclear cells were isolated from central nervous system of saline-treated, MOG35–55-immunized, MCMV-infected, and MCMV-infected and 
MOG35–55-immunized mice, 15 days after MOG35–55 immunization percentages of classically (CD11c+) and alternatively (CD206+) microglia are presented as 
mean + SE (8–10 mice per group). Data were analyzed with Student’s t-test and ANOVA: *P < 0.05, **P < 0.005, and ***P < 0.001.
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found in Lewis rats immunized with MOG35–55 (42), while cross-
reactivity between CMV981–1,003 and MOG34–56 was found in rhesus 
monkeys (43). Immunization of rhesus monkeys with human 
CMV981–1,003 peptide induced expansion of MOG34–56-specific 
T cells (43). Female SJL/J mice primed with vaccinia virus that 
contain PLP gene and later challenged with MCMV-developed 
lesions in white matter regions in the brains (28). Other studies 
on primates also support the role of CMV in MS pathogenesis 
(44, 45). Recently, Juranic Lisnic et al. demonstrated that MCMV 
infection of murine fibroblasts induced highest expression of 
interferon β, transcriptional factor T-bet, chemokine CXCL10 
(46), and the role of these markers of Th1 cells, in EAE pathogen-
esis is well known (47–49).
However, there was no evidence that MCMV infection may 
directly facilitate EAE. Here, we show that adult MCMV infection 
overcomes resistance of BALB/c mice to induction of EAE with 
MOG35–55 peptide. The disease is characterized by typical clinical 
signs (Figure 1A) seen in susceptible C57BL/6 mice and massive 
brain and spinal cord infiltrations (Figures 1E,F). It should be 
noted that brain infiltrates are more significant in BALB/c mice 
treated with encephalitogen then in “classical” EAE in C57BL/6 
mice. It appears that the disease after infection  +  MOG35–55 
challenge in otherwise resistant mice is more similar to MS than 
classical EAE (50). While in C57BL/6 mice, CD4+ cells dominate 
in CNS infiltrates in the experiments presented here, there 
was similar number of CD4+ and CD8+ cells in the infiltrates 
(Figure 1).
Encephalitogenity of CD4+ T cells in the infiltrates in BALB/c 
mice is further documented by their expression of chemokine 
receptors CXCR3 (Figure  2E), whose blockade during EAE 
induction attenuated the disease (51), and CCR6 receptor known 
to have the key role in development of initial autoimmune infil-
tration in the CNS (52, 53). While γHV-68 infection in C57BL/6 
mice with EAE leads to almost exclusive infiltration with Th1 
cells (7), in the CNS of MCMV-infected BALB/c mouse with 
EAE there is almost equal participation of Th1 and Th17 cell-
expressing IFN-γ and T-bet (Th1) and IL-17 and RORγt (Th17) 
(Figures 2C,D). Moreover, inflammatory infiltrates in MCMV-
pretreated BALB/c mice immunized with MOG35–55 contained 
CD8+ cell-expressing T1 and T17 transcriptional factors and 
corresponding cytokines TNF-α and IFN-γ (Tc1) and IL-17 
(Tc17 cells) (Figures 2C,D). Interestingly, it was suggested that 
Tc17 cells are required for Th17 accumulation and development 
of MS (54). Patients with early-stage MS harbor a greater number 
of Tc17 cells in the cerebrospinal fluid than in peripheral blood 
that contribute to the initiation of CNS autoimmunity (54). Since 
in the CNS of BALB/c mice with neonatal MCMV infection but 
without immunization with MOG35–55 dominates Tc1 cells (IFN-γ 
and T-bet+) (55), it appears that the newly developing autoim-
mune process attracts a different population of CD8+ cells (IL-17 
producing) that contribute to autoimmune process (54).
Significant accumulation of CD8+ cells in the infiltrates 
and their role in autoimmune pathogenesis is documented by 
clinical signs and typical pathology complemented by specific-
ity of infiltrating cells. Ex vivo restimulation with MOG35–55 
leads to significant increase of CD8+ cell-producing IFN-γ in 
MCMV + MOG35–55 BALB/c mice (Figure 3C). This finding is 
at variance with our finding in C57BL/6 mice. CD8+ cells from 
EAE C57BL/6 mice did not responded to restimulation with 
MOG35–55 (Figure  3C). Further, MOG35–55 responsive CD8+ 
cells in MCMV  +  MOG35–55 BALB/c mice were not specific 
for viral epitopes pp89 and m164 (Figure 3D) implicating that 
CD8+ cell contributes to autoimmune process in this model of 
EAE. This finding is in line with previous report that initiation 
of autoimmune process in CNS with CD4+ T cells is followed 
with spreading to myelin-specific CD8+ T cells that are capable 
of direct recognition of oligodendrocytes and contribute to 
tissue damage (56). Similarly, heighten EAE in C57BL/6 mice 
infected with γHV-68 is accompanied with infiltration of brain 
parenchyma with CD8+IFN-γ+granzyme+ cells (7). However, 
specificity for autoantigen of these inflammatory and cytolytic 
CD8+ cells in γHV-68-infected C57BL/6 mice was not studied 
(7). Finding that mice with depletion of CD4+ cells after MCMV 
infection and before MOG35–55 immunization did not develop the 
disease (Figure 3A) contributes to the conclusion that MCMV-
infected BALB/c mice developed autoimmune neuropathology. 
Persistence of CNS infiltrations and MOG35–55-specific CD4+ 
and CD8+ cells in CNS of BALB/c mice 2 months after MOG35–55 
immunization that were infected 3 months previously (Figure 4) 
also proving autoimmune nature of the disease. Thus although 
CD4+ cells are required, it appears that CD8+ cells are the main 
effector cells.
MCMV infection significantly increases proportion of dendritic 
cells (CD11c+), plasmocitoid dendritic cells (CD11c+PDCA1+) in 
peripheral lymph nodes (Figure 5A) compared to immunization 
with MOG35–55. Further higher percentage of dendritic cells in 
lymph nodes in MCMV-infected mice is accompanied with 
higher percentage of CCR2+ dendritic cells (Figure  5B). It is 
known that MCMV encodes proinflammatory factor (MCK-2), 
analog of chemokine CCL2 (57) that enhances monocyte recruit-
ment and viral dissemination (58). Then, higher percentage of 
dendritic cells in inguinal lymph nodes of MCMV-infected mice 
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